{
  "ticker": "MLYS",
  "company_name": "Mineralys Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06150924",
      "title": "Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Chronic Kidney Disease",
      "start_date": "2023-12-14",
      "completion_date": "2025-04-23",
      "enrollment": 0,
      "sponsor": "Mineralys Therapeutics Inc."
    },
    {
      "nct_id": "NCT05001945",
      "title": "Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypertension, Renal",
      "start_date": "2021-07-01",
      "completion_date": "2022-10-07",
      "enrollment": 0,
      "sponsor": "Mineralys Therapeutics Inc."
    },
    {
      "nct_id": "NCT05769608",
      "title": "A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypertension",
      "start_date": "2023-03-13",
      "completion_date": "2025-01-15",
      "enrollment": 0,
      "sponsor": "Mineralys Therapeutics Inc."
    },
    {
      "nct_id": "NCT05968430",
      "title": "Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "Hypertension",
      "start_date": "2023-07-14",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "Mineralys Therapeutics Inc."
    },
    {
      "nct_id": "NCT06785454",
      "title": "A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Obstructive Sleep Apnea, Hypertension",
      "start_date": "2025-02-28",
      "completion_date": "2025-12-29",
      "enrollment": 0,
      "sponsor": "Mineralys Therapeutics Inc."
    },
    {
      "nct_id": "NCT06153693",
      "title": "Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Hypertension",
      "start_date": "2023-11-22",
      "completion_date": "2025-01-24",
      "enrollment": 0,
      "sponsor": "Mineralys Therapeutics Inc."
    }
  ],
  "summary": {
    "total_trials": 6,
    "by_phase": {
      "PHASE2": 4,
      "PHASE3": 2
    },
    "by_status": {
      "COMPLETED": 5,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 1,
    "completed_trials": 5,
    "conditions": [
      "Chronic Kidney Disease",
      "Hypertension",
      "Hypertension, Renal",
      "Obstructive Sleep Apnea, Hypertension"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:01.510617",
    "search_query": "Mineralys Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Mineralys+Therapeutics,+Inc."
  }
}